April 5, 2018 / 9:41 AM / 14 days ago

BRIEF-CO DON: Successful Conclusion Of Phase II Trial 'co.dis'

Reuters Staff

1 Min Read

April 5 (Reuters) - Co Don AG:

* CONCLUSION OF PHASE II TRIAL ‘CO.DIS’ DEMONSTRATES EFFICACY AND SAFETY OF EU-AUTHORISED PHARMACEUTICAL PRODUCT SPHEROX Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.